STOCK TITAN

RDNT insider filing: 35,000 shares planned sale via Merrill Lynch

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for RadNet, Inc. (RDNT): The filer notified the SEC of a proposed sale of 35,000 common shares on 09/15/2025 through Merrill Lynch (Chandler, AZ) on NASDAQ, with an aggregate market value of $2,590,350.00. The shares were acquired as equity compensation in multiple grants dated between 01/02/2014 and 01/03/2017, totaling listed lots of 8,353; 12,018; 12,982; 1,638; and 9 shares. The filer reports no securities sold in the past three months for the account. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

  • Full disclosure filed: The filer submitted a Form 144 specifying broker, share count, and aggregate market value.
  • Securities originated from equity compensation: Acquisition rows list employee/equity compensation grants dated 2013–2017.
  • No recent sales: The filer reported "Nothing to Report" for securities sold during the past three months.

Negative

  • None.

Insights

TL;DR: Routine Form 144 filing disclosing a planned sale of 35,000 RDNT shares acquired via equity compensation.

This filing is a standard Rule 144 notice documenting an intended sale by an insider or person subject to Rule 144 aggregation rules. Key facts are the 35,000-share block, the $2,590,350 aggregate market value, the broker 09/15/2025. The acquisition rows show the shares were granted as employee/equity compensation across grants dated 2013–2017, which supports that the shares are vesting/granted stock rather than open-market purchases. The filing states there were no sales in the past three months by the account.

TL;DR: Disclosure aligns with insider-sale reporting requirements; nothing in the form indicates undisclosed company developments.

The document contains the required seller representation that no material nonpublic information exists. The granular acquisition dates and nature

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RadNet's (RDNT) Form 144 disclose?

The Form 144 discloses a proposed sale of 35,000 common shares on 09/15/2025 via Merrill Lynch, valued at $2,590,350.00.

How were the RDNT shares being sold acquired?

The shares were acquired as employee/equity compensation in multiple grants dated between 01/02/2014 and 01/03/2017.

Did the filer sell RDNT securities in the last three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Which broker and exchange are named in the Form 144 for RDNT?

The broker is listed as Merrill Lynch, 2555-2595 W Chandler Blvd, Chandler AZ 85224, and the exchange is NASDAQ.

What is the aggregate market value reported for the proposed RDNT sale?

The aggregate market value reported is $2,590,350.00.
Radnet

NASDAQ:RDNT

RDNT Rankings

RDNT Latest News

RDNT Latest SEC Filings

RDNT Stock Data

5.73B
67.21M
12.73%
94.2%
7.83%
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES